Stryker Debt to Equity Ratio 2010-2025 | SYK

Current and historical debt to equity ratio values for Stryker (SYK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Stryker debt/equity for the three months ending March 31, 2025 was 0.69.
Stryker Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $25.08B $20.93B 1.20
2024-12-31 $22.34B $20.63B 1.08
2024-09-30 $23.68B $20.15B 1.18
2024-06-30 $19.37B $19.76B 0.98
2024-03-31 $20.23B $19.17B 1.06
2023-12-31 $21.32B $18.59B 1.15
2023-09-30 $20.14B $17.91B 1.13
2023-06-30 $20.05B $17.36B 1.16
2023-03-31 $19.94B $16.90B 1.18
2022-12-31 $20.27B $16.62B 1.22
2022-09-30 $19.52B $16.46B 1.19
2022-06-30 $20.36B $15.67B 1.30
2022-03-31 $21.09B $15.05B 1.40
2021-12-31 $19.75B $14.88B 1.33
2021-09-30 $19.97B $14.18B 1.41
2021-06-30 $19.88B $13.82B 1.44
2021-03-31 $19.95B $13.50B 1.48
2020-12-31 $21.25B $13.08B 1.62
2020-09-30 $19.30B $12.99B 1.49
2020-06-30 $18.73B $12.75B 1.47
2020-03-31 $16.33B $13.12B 1.25
2019-12-31 $17.36B $12.81B 1.36
2019-09-30 $14.34B $12.32B 1.17
2019-06-30 $14.41B $11.94B 1.21
2019-03-31 $14.24B $11.69B 1.22
2018-12-31 $15.50B $11.73B 1.32
2018-09-30 $12.22B $9.86B 1.24
2018-06-30 $12.11B $9.46B 1.28
2018-03-31 $12.91B $9.22B 1.40
2017-12-31 $12.22B $9.98B 1.22
2017-09-30 $11.06B $10.43B 1.06
2017-06-30 $11.26B $10.04B 1.12
2017-03-31 $10.81B $9.70B 1.11
2016-12-31 $10.89B $9.55B 1.14
2016-09-30 $10.86B $9.33B 1.16
2016-06-30 $11.42B $9.10B 1.26
2016-03-31 $10.86B $8.81B 1.23
2015-12-31 $7.71B $8.51B 0.91
2015-09-30 $7.43B $8.48B 0.88
2015-06-30 $8.31B $8.51B 0.98
2015-03-31 $8.26B $8.32B 0.99
2014-12-31 $8.68B $8.60B 1.01
2014-09-30 $8.89B $8.62B 1.03
2014-06-30 $8.23B $9.00B 0.91
2014-03-31 $7.10B $9.06B 0.78
2013-12-31 $6.70B $9.05B 0.74
2013-09-30 $6.15B $8.74B 0.70
2013-06-30 $5.78B $8.60B 0.67
2013-03-31 $5.63B $8.46B 0.67
2012-12-31 $4.61B $8.60B 0.54
2012-09-30 $4.42B $8.36B 0.53
2012-06-30 $4.31B $7.95B 0.54
2012-03-31 $4.44B $8.02B 0.55
2011-12-31 $4.46B $7.68B 0.58
2011-09-30 $4.53B $7.56B 0.60
2011-06-30 $3.82B $7.78B 0.49
2011-03-31 $3.78B $7.45B 0.51
2010-12-31 $3.72B $7.17B 0.52
2010-09-30 $3.47B $7.31B 0.47
2010-06-30 $3.32B $6.75B 0.49
2010-03-31 $3.43B $6.67B 0.51
2009-12-31 $2.48B $6.60B 0.38
2009-09-30 $2.02B $6.44B 0.31
2009-06-30 $1.87B $6.06B 0.31
2009-03-31 $1.96B $5.63B 0.35
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $143.347B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.811B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00